Pablo Aschner

6.1k total citations · 3 hit papers
92 papers, 4.2k citations indexed

About

Pablo Aschner is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Molecular Biology. According to data from OpenAlex, Pablo Aschner has authored 92 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Epidemiology and 14 papers in Molecular Biology. Recurrent topics in Pablo Aschner's work include Diabetes Management and Research (39 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (32 papers) and Diabetes Treatment and Management (29 papers). Pablo Aschner is often cited by papers focused on Diabetes Management and Research (39 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (32 papers) and Diabetes Treatment and Management (29 papers). Pablo Aschner collaborates with scholars based in Colombia, United States and Argentina. Pablo Aschner's co-authors include Debora Williams‐Herman, Carolyn Mickel, Mark Kipnes, Jared Lunceford, Juliana C.N. Chan, N.M. Baldé, Dana Dabelea, Anna R. Kahkoska, Craig Jefferies and Elizabeth J. Mayer‐Davis and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Diabetes Care.

In The Last Decade

Pablo Aschner

88 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes

2006 721 citations Pablo Aschner et al. profile →
ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents

2018 429 citations Elizabeth J. Mayer‐Davis, Anna R. Kahkoska et al. Pediatric Diabetes profile →
Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management

2019 352 citations Pablo Aschner, Lawrence A. Leiter et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pablo Aschner Colombia	33	3.0k	999	749	708	447	92	4.2k
Marc Evans United Kingdom	39	3.6k 1.2×	991 1.0×	1.2k 1.6×	419 0.6×	522 1.2×	183	5.5k
Swapnil Rajpathak United States	40	2.3k 0.8×	790 0.8×	859 1.1×	325 0.5×	759 1.7×	121	5.2k
Kasia J. Lipska United States	35	3.3k 1.1×	660 0.7×	796 1.1×	477 0.7×	436 1.0×	120	5.0k
Billy S. Collins United States	16	2.7k 0.9×	856 0.9×	758 1.0×	497 0.7×	682 1.5×	35	3.9k
Marília Brito Gomes Brazil	33	2.3k 0.7×	739 0.7×	798 1.1×	574 0.8×	583 1.3×	217	4.5k
Bruno Guerci France	39	3.6k 1.2×	1.6k 1.6×	1.3k 1.8×	1.1k 1.5×	515 1.2×	210	5.1k
Ho‐Young Son South Korea	27	1.9k 0.6×	795 0.8×	601 0.8×	337 0.5×	540 1.2×	85	3.7k
Jae Hyeon Kim South Korea	39	2.9k 0.9×	1.7k 1.7×	981 1.3×	823 1.2×	885 2.0×	280	5.7k
Helena W. Rodbard United States	37	4.4k 1.4×	1.5k 1.5×	1.8k 2.4×	465 0.7×	667 1.5×	100	5.9k
Alice Cheng Canada	24	2.1k 0.7×	644 0.6×	701 0.9×	363 0.5×	348 0.8×	105	3.5k

Countries citing papers authored by Pablo Aschner

Since Specialization

Citations

This map shows the geographic impact of Pablo Aschner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Aschner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Aschner more than expected).

Fields of papers citing papers by Pablo Aschner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Aschner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Aschner. The network helps show where Pablo Aschner may publish in the future.

Co-authorship network of co-authors of Pablo Aschner

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Aschner. A scholar is included among the top collaborators of Pablo Aschner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Aschner. Pablo Aschner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Acosta‐Reyes, Jorge, et al.. (2025). Effectiveness of a community intervention program on healthy lifestyles (PREDICOL) among adults with prediabetes in two Latin American cities: A quasi-experimental study. Primary care diabetes. 19(3). 277–287.

Torregrosa, Lilián, et al.. (2023). Safety and efficacy of P2Et extract from Caesalpinia spinosa in breast cancer patients: study protocol for a randomized double blind phase II clinical trial (CS003-BC). BMC Complementary Medicine and Therapies. 23(1). 309–309. 2 indexed citations

Molina, Rafael Tuesca, et al.. (2023). Glycemic status and health-related quality of life (HRQOL) in populations at risk of diabetes in two Latin American cities. Quality of Life Research. 32(8). 2361–2373. 4 indexed citations

Gómez, Ana María, et al.. (2021). Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 15(2). 499–503. 16 indexed citations

Chan, Juliana C.N., Juan José Gagliardino, Hasan İlkova, et al.. (2021). One in Seven Insulin-Treated Patients in Developing Countries Reported Poor Persistence with Insulin Therapy: Real World Evidence from the Cross-Sectional International Diabetes Management Practices Study (IDMPS). Advances in Therapy. 38(6). 3281–3298. 14 indexed citations

Davis, Timothy M. E., Hillary Mulder, Yuliya Lokhnygina, et al.. (2018). Effect of race on the glycaemic response to sitagliptin: Insights from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). Diabetes Obesity and Metabolism. 20(6). 1427–1434. 23 indexed citations

Mayer‐Davis, Elizabeth J., Anna R. Kahkoska, Craig Jefferies, et al.. (2018). ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatric Diabetes. 19. 7–19. 429 indexed citations breakdown →

Ibrahim, Mahmoud, Jaakko Tuomilehto, Pablo Aschner, et al.. (2018). Global status of diabetes prevention and prospects for action: A consensus statement. Diabetes/Metabolism Research and Reviews. 34(6). e3021–e3021. 40 indexed citations

Nieto‐Martínez, Ramfis, Juan P. González‐Rivas, Eunice Ugel, et al.. (2017). Cardio-Metabolic Health Venezuelan Study (EVESCAM): Design and Implementation.. PubMed. 58(1). 56–69. 11 indexed citations

10.

Malhan, S, Ambady Ramachandran, Jean Claude Mbanya, et al.. (2016). Type 2 Diabetes in Turkey – A Cost of Illness Study. Value in Health. 19(7). A669–A669. 3 indexed citations

11.

Aschner, Pablo, et al.. (2015). Economic Evaluation Of Four Schemes For Screening And Diagnosis Of Type 2 Diabetes In Adults In Colombia. Value in Health. 18(7). A356–A356. 4 indexed citations

12.

Nazare, Julie‐Anne, Jessica Smith, Anne‐Laure Borel, et al.. (2014). Usefulness of Measuring Both Body Mass Index and Waist Circumference for the Estimation of Visceral Adiposity and Related Cardiometabolic Risk Profile (from the INSPIRE ME IAA Study). The American Journal of Cardiology. 115(3). 307–315. 126 indexed citations

13.

Elgart, Jorge F., et al.. (2014). Dapagliflozin versus sulfonylurea as an add-on therapy to metformin: A cost-effectiveness analysis in Colombia. Value in Health. 17(3). A247–A247. 2 indexed citations

14.

Borel, Anne‐Laure, Jessica Smith, Pablo Aschner, et al.. (2014). Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance. International Journal of Obesity. 39(3). 495–501. 43 indexed citations

15.

Aschner, Pablo. (2013). The importance of estimating abdominal obesity. 38(3). 112–113. 1 indexed citations

16.

Aschner, Pablo, et al.. (2010). Practical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes Management. International Journal of Clinical Practice. 64(3). 305–315. 56 indexed citations

17.

Aschner, Pablo. (2010). Metabolic syndrome as a risk factor for diabetes. Expert Review of Cardiovascular Therapy. 8(3). 407–412. 61 indexed citations

18.

Aschner, Pablo, et al.. (2007). The team approach to diabetes management: partnering with patients. International Journal of Clinical Practice. 61(157). 22–30. 19 indexed citations

19.

Eliaschewitz, Freddy G., et al.. (2006). Therapy in Type 2 Diabetes: Insulin Glargine vs. NPH Insulin Both in Combination with Glimepiride. Archives of Medical Research. 37(4). 495–501. 96 indexed citations

20.

Aschner, Pablo. (2002). Diabetes trends in Latin America. Diabetes/Metabolism Research and Reviews. 18(S3). S27–S31. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact